HuGE Literature Finder
Records
1
-
6
| Distinct Afatinib Resistance Mechanisms Identified in Lung Adenocarcinoma Harboring an EGFR Mutation. Molecular cancer research : MCR 2017 07 15 (7): 915-928. Yamaoka Toshimitsu, Ohmori Tohru, Ohba Motoi, Arata Satoru, Murata Yasunori, Kusumoto Sojiro, Ando Koichi, Ishida Hiroo, Ohnishi Tsukasa, Sasaki Yasutsu |
| The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer. PloS one 2017 12 (7): e0181527. Al-Saad Samer, Richardsen Elin, Kilvaer Thomas K, Donnem Tom, Andersen Sigve, Khanehkenari Mehrdad, Bremnes Roy M, Busund Lill-To |
| The Clinical Significance of the Insulin-Like Growth Factor-1 Receptor Polymorphism in Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation. International journal of molecular sciences 2016 May 17 (5): . Liu Tu-Chen, Hsieh Ming-Ju, Liu Ming-Che, Chiang Whei-Ling, Tsao Thomas Chang-Yao, Yang Shun- |
| Putative predictive biomarkers of survival in patients with metastatic pancreatic adenocarcinoma treated with gemcitabine and ganitumab, an IGF1R inhibitor. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Aug 19 (15): 4282-9. McCaffery Ian, Tudor Yanyan, Deng Hongjie, Tang Rui, Suzuki Samuel, Badola Sunita, Kindler Hedy L, Fuchs Charles S, Loh Elwyn, Patterson Scott D, Chen Li, Gansert Jennifer |
| Survival is associated with genetic variation in inflammatory pathway genes among patients with resected and unresected pancreatic cancer. Annals of surgery 2013 Jan . Reid-Lombardo KM, Fridley BL, Bamlet WR, Cunningham JM, Sarr MG, Petersen GM |
| Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer. Gastroenterology 2010 Aug 139 (2): 464-73, 473.e1-3. Dong Xiaoqun, Javle Milind, Hess Kenneth R, Shroff Rachna, Abbruzzese James L, Li Dongh |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 25, 2022
- Content source: